Only one report demonstrated that bisacurone inhibited adhesion of inflammatory monocytes and oral cancer cells to human umbilical vein endotherial cells through down-regulation of tumor necrosis factor α-activated vascular adhesion molecule-1,(25) suggesting that bisacurone has the potential to suppress inflammation. Here, TNF is linked to lip and oral cavity carcinoma.